Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 5 |
2023 | 1 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer.
Cancers (Basel). 2023 Feb 5;15(4):1008. doi: 10.3390/cancers15041008.
Cancers (Basel). 2023.
PMID: 36831353
Free PMC article.
The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan.
Yang SH, Chiang NJ, Chiu SC, Chou WC, Bai LY, Li CP, Su YY, Chiu TJ, Chuang SC, Peng CM, Chan DC, Chen JS, Yen CJ, Chen YY, Chiu CF, Chen LT, Shan YS.
Yang SH, et al. Among authors: chiu sc.
Am J Cancer Res. 2022 Apr 15;12(4):1884-1898. eCollection 2022.
Am J Cancer Res. 2022.
PMID: 35530292
Free PMC article.
Item in Clipboard
Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study.
Su YY, Chiang NJ, Li CP, Yen CJ, Yang SH, Chou WC, Chen JS, Chiu TJ, Chen YY, Chuang SC, Bai LY, Chiu CF, Peng CM, Chan DC, Chiu SC, Yang YH, Shan YS, Chen LT.
Su YY, et al. Among authors: chiu sc.
Front Oncol. 2022 Jun 22;12:800842. doi: 10.3389/fonc.2022.800842. eCollection 2022.
Front Oncol. 2022.
PMID: 35814374
Free PMC article.
Item in Clipboard
The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma.
Chiang NJ, Shan YS, Li CP, Yang SH, Su YY, Chiu SC, Bai LY, Chuang SC, Chan DC, Yen CJ, Peng CM, Chiu TJ, Chen YY, Chen JS, Chou WC.
Chiang NJ, et al. Among authors: chiu sc.
Am J Cancer Res. 2022 Nov 15;12(11):5062-5073. eCollection 2022.
Am J Cancer Res. 2022.
PMID: 36504882
Free PMC article.
Item in Clipboard
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin.
Chiu TJ, Yang SH, Chiu SC, Hsueh SW, Chiang NJ, Li CP, Bai LY, Cheng FM, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Su YY, Chen YY, Chen JS, Chou WC.
Chiu TJ, et al. Among authors: chiu sc.
J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):670-681. doi: 10.1002/jhbp.1128. Epub 2022 Mar 2.
J Hepatobiliary Pancreat Sci. 2022.
PMID: 35182031
Item in Clipboard
Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin.
Chen YY, Hsueh SW, Yang SH, Chiu SC, Chiang NJ, Chiu TJ, Li CP, Bai LY, Chiu CF, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Chen JS, Chou WC.
Chen YY, et al. Among authors: chiu sc.
Am J Cancer Res. 2022 Sep 15;12(9):4267-4278. eCollection 2022.
Am J Cancer Res. 2022.
PMID: 36225629
Free PMC article.
Item in Clipboard
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer.
Tang CY, Yang SH, Li CP, Su YY, Chiu SC, Bai LY, Shan YS, Chen LT, Chuang SC, Chan DC, Yen CJ, Peng CM, Chiu TJ, Chen YY, Chen JS, Chiang NJ, Chou WC.
Tang CY, et al. Among authors: chiu sc.
Pancreatology. 2024 Mar 25:S1424-3903(24)00076-0. doi: 10.1016/j.pan.2024.03.014. Online ahead of print.
Pancreatology. 2024.
PMID: 38565467
Item in Clipboard
Cite
Cite